HeartFlow stakes $90m step toward $150m Series E

HeartFlow took a $90 million step toward the $150 million it hopes to raise in a Series E round for the cardiac imaging technology it’s marketing. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across coronary lesions. Last week reports surfaced that the company was eyeing a $150 million raise, which would vault it into “unicorn” territory with a $1.4 billion valuation. HeartFlow’s $99.9 million Series D valued the company at $760 million in May 2016. In a Nov. 30 regulatory filing released yesterday, HeartFlow reported raising $90.0 million from a pair of unnamed investors in an equity round launched Nov. 20. Earlier this month the company won a new technology ambulatory payment classification from the Centers for Medicare & Medicaid Services. In late August, HeartFlow said it won positive medical policies for its HeartFlow FFRct fractional flow reserve analysis system from three separate Blue Cross Blue Shield providers. The post HeartFlow stakes $90m step toward $150m Series E appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiovascular Funding Roundup Imaging Wall Street Beat HeartFlow Source Type: news